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Background: Hypointense lesions on T1-weighted images have important clinical
relevance in multiple sclerosis patients. Traditionally, spin-echo (SE) sequences are used
to assess these lesions (termed black holes), but Fast Spoiled Gradient-Echo (FSPGR)
sequences provide an excellent alternative.
Objective: To determine whether the contrast difference between T1 hypointense
lesions and the surrounding normal white matter is similar on the two sequences, whether
different lesion types could be identified, and whether the clinical relevance of these
lesions types are different.
Methods: Seventy-nine multiple sclerosis patients’ lesions were manually segmented,
then registered to T1 sequences. Median intensity values of lesions were identified on all
sequences, then K-means clustering was applied to assess whether distinct clusters of
lesions can be defined based on intensity values on SE, FSPGR, and FLAIR sequences.
The standardized intensity of the lesions in each cluster was compared to the intensity
of the normal appearing white matter in order to see if lesions stand out from the white
matter on a given sequence.
Results: 100% of lesions on FSPGR images and 69% on SE sequence in cluster #1
exceeded a standardized lesion distance of Z = 2.3 (p < 0.05). In cluster #2, 78.7%
of lesions on FSPGR and only 17.7% of lesions on SE sequence were above this cutoff
value, meaning that these lesions were not easily seen on SE images. Lesion count in the
second cluster (lesions less identifiable on SE) significantly correlated with the Expanded
Disability Status Scale (EDSS) (R: 0.30, p ≤ 0.006) and with disease duration (R: 0.33, p
≤ 0.002).
Conclusion: We showed that black holes can be separated into two distinct clusters
based on their intensity values on various sequences, only one of which is related to
clinical parameters. This emphasizes the joint role of FSPGR and SE sequences in the
monitoring of MS patients and provides insight into the role of black holes in MS.
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INTRODUCTION
Multiple sclerosis (MS) is a chronic, progressive disease
affecting the central nervous system in young adults leading
to demyelination and axonal loss (1). Conventional T1 (T1w)-
and T2-weighted (T2w) magnetic resonance (MR) imaging has
a key role in the diagnosis and in the follow-up of MS, but the
relationship between clinical symptoms and white matter lesions
is not straightforward (2). White matter lesions on T2w images
are hyperintense and correspond to several histopathological
changes such as edema or demyelination (3).
In contrast, hypointense white matter lesion on T1w images,
the so-called black holes (BHs) correspond to axonal loss (4).
The first description of the association between BHs and the
clinical state of MS patients was published by Truyen et al.
Using spin-echo (SE) MRI sequences in their 40-month follow-
up study they showed that patients’ baseline disabilities correlated
significantly with BH lesion load, and in the case of secondary
progressive MS, the accumulation of BHs contributed to the
progression rate as well. They suggested that the presence of
BHs led to a failed remission (5). BHs could be divided into
two major types, namely, acute and persisting BHs. Acute BHs
are contrast-enhancing lesions, and during the course of the
disease, 20–40% of the acute BHs turns into persisting BHs (4, 6).
BHs have high water content and correspond to irreversible MS
pathology (7–10). In addition, the pattern of spatial distribution
of BHs has preferred loci in the brain; for example, BHs are
rarely present around the lateral ventricles but appear more often
in the supratentorial region, with an effect on supratentorial
brain volume and consequently cerebral atrophy (11). It was also
reported that BHs may play a role in the conversion of clinically
isolated syndrome to MS (12).
Many studies investigated the possible contribution of BHs
to the clinical and cognitive state or their worsening in
patients with MS. Based on these studies, BHs may present a
possible resolution to the clinico-radiological paradox. Cognitive
dysfunctions, reported in 43–70% of MS patients, mainly affect
the information processing speed, visuospatial memory, and
executive functions (13, 14). Parietal and frontal BHs were
shown as a significant predictor of attention and non-verbal
intelligence as well as phonemic verbal fluency deficit (7). Giorgio
et al. demonstrated in a follow-up study that BH lesion load
and lesion count were associated not just with the baseline
EDSS scores (which quantifies and monitors the disability
of MS patients), but also with its worsening over a 10-year
period (8).
After it was established that BHs contribute to the course and
progression of the disease and have clinical relevance in MS,
the main focus of researches was directed toward whether any
variation in BH appearance could have clinical relevance. There
are only a few studies conducted in this regard. Adusumilli et al.
showed that BHs and gray holes (e.g., less hypointense lesions),
presumably measured on SE images can be differentiated with
high reliability and correlated well with different clinical and
cognitive measures (15). Tam in another study proved that BHs
with lower intensity compared to other BHs have higher clinical
relevance (16).
Importantly, the correlation between T1 hypointense lesions
to pathological features and clinical symptoms was mainly
investigated on SE T1 weighted images. The downside of
this acquisition technique is the relatively longer acquisition
time. Fast spoiled gradient-echo (FSPGR) sequences are suitable
alternatives providing shorter acquisition times and/or improved
resolution. Hypointense lesions are also detectable on FSPGR
sequences, but the clinical relevance and the possible differences
in comparison to SE sequences have not been thoroughly studied.
In this study, we aimed (i) to determine whether the
contrast difference between white matter hypointensities and the
surrounding normal white matter is similar on SE and FSPGR
images, (ii) if two different lesion types could be identified based
on the intensities on the two sequences, and (iii) if the clinical
relevance of the two lesion types are different.
METHODS
Patients
In this study, 79 patients with relapsing-remitting MS (RRMS)
diagnosis were enrolled. Patients were recruited from the
Multiple Sclerosis Outpatient Clinic at the Department of
Neurology, University of Szeged. Clinical and demographic
parameters of the patient population are depicted in Table 1.
All patients were in stable clinical state, no relapses occurred
6 months preceding and following the study. This study
was approved by the Ethical Committee of the University of
Szeged (Ref.No.: 000002/2016/OTIG). All study participants gave
their written informed contribution in accordance with the
Declaration of Helsinki.
MR Imaging Acquisition
MR imaging was performed on a 3 T GE Discovery 750w MR
Scanner (GE Healthcare, Chalfont St. Giles, UK). In total, MR
images from 79 relapsing-remitting MS patients were acquired
as part of the routine clinical follow-up based on our recent
recommendation (17). In the analysis, the following sequences
were used: high-resolution T1 weighted anatomical images
[3D spoiled gradient-echo images with inversion recovery 3D
FSPGR IR: echo time (TE): 5.4ms; repetition time (TR): 2ms;
inversion time: 450ms; matrix: 256∗256; field of view (FOV):
25.6 × 25.6 cm; flip angle:12 degree; slice thickness: 1mm;
PURE intensity correction, NEX:1], CUBE T2 FLAIR for lesion
detection (TE: 135ms; TR: 6,700ms; TI: 1,827ms; matrix: 256 ×
224; FOV: 25× 22.5 cm; slice thickness: 1.4mm; post-processing:
ZIP512, ZIP2, NEX:1), SE T1 weighted images (TE: min full—
minimum TE without fractional TE; TR: 500ms; flip angle: 73
degree; matrix: 256 × 224; FOV: 24 × 19.2 cm; slice thickness:
3mm; NEX:2).
Image Analysis
All the image analyses were carried out using the tools of
the FSL software package (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/
FSL). All image (SE, FSPGR, and FLAIR) sequences were
intensity normalized prior to the following steps (18). After
removing the non-brain parts using BET (19), manual lesion-
outlining on FLAIR images for all patients was performed by
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(years) (mean ± std)
Number of relapses since
treatment onset; median
(range)
Treatment regimen Lesion load (mm3)
(mean ± std)
79 55 42.27 2 12.34 0 (0–10) DF-5.5% 7.09






DF, dimethyl fumarate; Te, teriflunomide; IFNb, interferon beta 1a; GA, glatiramer acetate; F, fingolimod; A, alemtuzumab; N, natalizumab.
KK and supervised by KZT. In order to analyze only those
lesions that are detectable on the 3mm slice thickness images
with certainty, lesions larger than 100 voxels were used in
the analyses. SE and FLAIR images were registered to 3D
FSPGR IR images with 6 DOF using FLIRT (20). The manually
outlined and lesion masks were brought into FSPGR space using
the previous registration matrices and trilinear interpolation.
Masks were thresholded at 0.5 and binarized to avoid the
enlargement due to the interpolation. Intensity values under
the individual lesion masks on both FSPGR and SE images
were extracted.
Tissue-type segmentation of the 3D FSPGR IR images was
performed by FMRIB’s Automated Segmentation Tool (FAST)
(21). Lesions were masked out from the white matter partial
volume images. Median intensity of the white matter, graymatter,
and cerebrospinal fluid (CSF) was defined on each sequence.
In order to estimate normalized brain volumes from FSPGR IR
images, FSL SIENAX was used (22).
Statistical Analysis
Altogether, data from 694 lesions was used in the statistical
analyses. The lesions’ median intensity values were calculated
on FSPGR and SE sequences and were divided by the
median intensity values of the white matter. These standardized
intensities of the FSPGR and SE sequences were analyzed with
one-sample Wilcoxon signed rank test to test whether the lesions
can be differentiated from the surrounding white matter (a ratio
different from 1).
In order to separate two different lesion types, K-means
clustering was carried out (IBM SPSS Statistic 23, https://
www.ibm.com/products/spss-statistics) on the lesion’s median
intensity values. Median lesion intensities per lesion from the
FSPGR, SE, and FLAIR sequences were used, the number of
clusters was set to 2; the iterate and classify method was
used, and the number of maximum iterations was set to
10. The K-means cluster algorithm creates clusters from the
dataset, placing centroids in a way that the data in a given
cluster have similar attributes or closeness to the centroid,
whilst the distance between clusters (centroids) is maximized
(23). In order to quantify how median intensity values of
the two lesion type clusters differ from the normal white
matter intensity profile, we employed a bootstrap-based approach
using a custom-made MATLAB script. To build up a null
distribution for each subject, 5,000 random intensity values
were sampled from subjectwise white matter voxels. A mean
distance, defined as the average ratio of all white matter voxel
intensities and the reference voxel intensity was calculated
for all 5,000 selected voxels. The similar distance of lesions’
median intensity was compared to this null-distribution and
converted to Z-scores (which we refer to later as standardized
lesion distance). This way, Z-scores take individual white
matter intensity profiles into account. To assess how lesion
type clusters can be separated from white matter voxels, we
calculated the percentage of lesions exceeding a standardized
lesion distance of Z = 2.3 for both lesion type clusters in
both sequences.
Bivariate Spearman rank correlation between clinical
parameters (EDSS, disease duration, number of relapses, and
number of relapses since the beginning of the treatment),
normalized brain volumes, and the number and volume of
lesions in the clusters was calculated. All results were corrected
for multiple comparison.
RESULTS
Separability of Lesions From the
Surrounding White Matter on T1 Weighted
Images
Our results showed that lesions on average were separable from
the surrounding whitematter on both FSPGR and SE images. The
intensity of the lesions was lower than white matter but higher
than gray matter (and CSF) (FSPGR CSF: Z = 22.82, p ≤ 0.001;
SE CSF: Z= 22.8, p≤ 0.001; FSPGRGM: Z= 13.83, p≤ 0.001; SE
GM: Z = 21.34, p ≤ 0.001; FSPGR WM: Z = −22.81, p ≤ 0.001;
SE WM: Z = −19.1, p ≤ 0.001). The standardized intensity of
lesions on the SE and FSPGR images were different (normalized
to white matter: U = 76491.5, p ≤ 0.001).
Albeit the intensity distributions of white matter lesions on
both the SE and FSPGR images partly overlapped with the white
matter intensities, the overlapping of the lesions on SE images
was more expressed (Figure 1).
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Grouping the Lesions Based on Their
Intensity
Based on their intensity values on the FSPGR, SE, and FLAIR
sequences, the K-means clustering algorithm grouped the 694
FIGURE 1 | Standardized intensities of lesions on FSPGR and SE images. The
median intensities of lesions were divided by the median intensity of the CSF,
GM, and WM, respectively. Hence, a standardized intensity value of 1 would
mean lesion intensity that does not stand out from the surrounding
tissue intensity.
lesions into two clusters: 224 in Cluster 1 and 470 lesions in
Cluster 2 (Figures 2, 3). The median intensity of lesions on
FSPGR sequence had the maximum influence in the formation
of the clusters (F = 1145.97), whilst median intensity values
FIGURE 3 | The two clusters of lesions on FSPGR and SE images. Images on
the left (A,C) are examples depict SE whilst images on the right (B,D) depict
FSPGR for Cluster 1 (yellow circle) and Cluster 2 (red circle), respectively.
FIGURE 2 | Separability of lesion clusters from white matter intensity in FSPGR and SE sequences. Histograms depict the probability density function of standardized
lesion distance (see Methods for more details) for the two lesion type clusters on FSPGR and SE sequences. The vertical red line depicts a standardized lesion
distance of Z = 2.3. PDF, probability density function.
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TABLE 2 | Summary of the results of K-means clustering.
1st cluster 2nd cluster
Number of cases n = 224 n = 470
Final cluster centers on FSPGR
(intensity value)
3525.20 4280.42
Final cluster centers on SE
(intensity value)
1701.23 1887.77
Final cluster centers on FLAIR
(intensity value)
2575.23 2555.67
Median intensity (range) on
FSPGR images
3,561 (2,259–3,886) 4,233 (3,988–4,797)
Median intensity (range) on SE
images
1,732 (1,142–2,022) 1,902 (1,717–2,090)
Median intensity (range) on
FLAIR images
2,558 (1,757–3,048) 2,603 (1,726–3,116)
The table shows the main characteristics of the two clusters of lesions derived from
K-means clustering.
of lesions on FLAIR had the most negligible effect on it (F =
0.74). The main characteristics of the two clusters of lesions is
summarized in Table 2.
The percentage of Cluster 1 lesions exceeded a standardized
lesion distance of Z = 2.3 was 100% for the FSPGR-sequence and
69% for the SE-sequence. As for Cluster 2 lesions, 78.7% exceeded
a standardized lesion distance of Z= 2.3 on the FSPGR-sequence
and 17.7% on the SE-sequence (see Figure 2 for further details).
In summary, lesions in the second cluster on FSPGR images were
clearly separable from the surrounding white matter; however,
on SE images, the lesions were close to the mean intensity of the
white matter, hence harder to visually detect.
Clinical Relevance of the Lesion Types
Spearman rank correlation values are summarized in Table 3.
Our results showed that the lesion count in Cluster 2 correlated
significantly with EDSS (R = 0.3, p ≤ 0.042), with disease
duration; (R = 0.33, p ≤ 0.014), and with the normalized brain
volume (R = −0.42, p ≤ 0.008). Also, the lesion volume of
Cluster 2 showed significant correlation with EDSS (R = 0.28,
p ≤ 0.07) disease duration (R = 0.41, p ≤ 0.007), and with the
normalized brain volume (R = −0.51, p ≤ 0.008), whilst no
significant correlation was found with lesion volume and lesion
count of the lesions in the Cluster 1.
Total lesion volume showed significant correlation with the
EDSS scores (R = 0.46, p ≤ 0.007), and disease duration (R =
0.33, p ≤ 0.014).
Furthermore, significant correlation was found between the
normalized brain volumes and EDSS scores (R = −0.46, p ≤
0.008), disease duration (R = −0.38, p ≤ 0.008), number of
relapses (R=−0.36, p≤ 0.008), and the number of relapses since
treatment onset (R = −0.31, p ≤ 0.036). Scatterplots depicting
the significant correlations are summarized in Figure 4.
DISCUSSION
In this study, we showed that (i) T1 hypointense lesions are
more easily detectable using an FSPGR sequence than an SE
sequence; (ii) Almost all of the T2 hyperintense lesions were
easily detectable on FSPGR, but only less than half of the lesions
were easily detected using a SE sequence; (iii) Interestingly,
lesions not standing out on SE sequences are the one which are
clinically more important; and (iv) the very same lesions are
correlated with brain atrophy.
Our results are interesting in the view of earlier investigations
suggesting a stronger correlation between clinical variables and
SE T1 hypointense lesions than T2 hyperintense lesions. Truyen
and colleagues showed that hypointense lesion load on the SE
images correlated with EDSS, but T2 hyperintense lesion load
did not. Importantly, this strong correlation was only significant
for secondary progressive MS (SPMS) patients (5). Enzinger
presented univariate correlation between the black-hole ratio
on SE (personal communication) at baseline and MS severity
score 10 years later, but the association did not hold if multiple
regressionmodel was used (24). The baseline black-hole ratio was
a significant predictor of conversion to secondary-progressive
multiple sclerosis (SPMS), but when baseline clinical variables
were inserted into the models no significant predictive value
remained among the investigated MRI parameters (24). In a
Multiple Sclerosis Collaborative Research Group (MSCRG) trial
of interferon beta-1a, there was a significant correlation between
baseline T1 lesion load (presumably SE) and EDSS, but the
correlation with T2 lesion load was virtually identical (25).
Similarly, in Giorgio’s study, both the volume and count of
baseline T1w and T2w lesions correlated with the EDSS scores,
but the combination of baseline count and volume of T1w
lesions predicted more precisely the 10-year EDSS worsening (8).
Moreover, most of the studies describing correlation between
clinical parameters and black-hole lesion load were carried out
on SPMS patients (26, 27).
We showed that the volume and number of T1 hypointense
lesions in Cluster 2 significantly correlated with the normalized
brain volumes of the patients. There are only a few publications
examining the relationship between BHs and cerebral atrophy.
Sailer et al. showed that an increase in T1 lesion load correlated
with the increase of cerebral atrophy during an 18-month follow-
up study (28). Paolillo et al. found significant correlation between
the supratentorial brain volume and T1 total hypointense lesion
load (11). Both studies suggested that the link between the
volume increase of T1 hypointense lesions and cerebral atrophy is
that local tissue damages and axonal loss might lead to increased
neuronal packing density as well as contraction scarring caused
by gliosis.
Our results are concordant with these former studies in that
there was no correlation between Cluster 1 lesion number or
volume with the clinical parameters. These are the lesions that
were well differentiated on SE sequence from surrounding white
matter, most comparable to traditional black-holes detected on
SE images.
The importance of our findings is emphasized by Tam’s studies
(16, 29). The first study of a smaller population of mixed RR and
SPMS patients showed stronger correlation between EDSS and
black-hole volume when only the darkest voxels were considered
(16). The consecutive study in a larger SPMS group showed
the opposite, best correlation between MSFC when the brightest
part of the hypointense lesions were also considered (most
inclusive lesion masks) (29). These results were strengthened
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TABLE 3 | Significant correlations between clinical data and the volume and count of clustered lesions.
EDSS Disease duration Number of relapses Number of relapses since
treatment onset
Normalized brain volume
CL-1 lesion count R = 0.12, p = 1.0 R = 0.05, p = 1.0 R = 0.006, p = 1.0 R = −0.15, p = 1.0 R = −0.06, p = 1.0
CL-1 lesion volume R = 0.14, p = 1.0 R = 0.008, p = 1.0 R = 0.07, p = 1.0 R = −0.18, p = 0.77 R = −0.09, p = 1.0
Cl-2 lesion count R = 0.30, p = 0.042 R = 0.33, p = 0.014 R = 0.02, p = 1.0 R = 0.13, p = 1.0 R = –0.42, p = 0.008
CL-2 lesion volume R = 0.28, p = 0.007 R = 0.41, p = 0.007 R = 0.18, p = 0.70 R = 0.28, p = 0.07 R = –0.51, p = 0.008
Lesion volume (total) R = 0.46, p = 0.007 R = 0.33, p = 0.014 R = 0.21, p = 0.36 R = 0.21, p = 0.38 –
Lesion count (total) R = 0.29, p = 0.056 R = 0.28, p = 0.07 R = −0.002, p = 1.0 R = 0.04, p = 1.0 –
Normalized brain volume R = –0.46, p = 0.008 R =–0.38, p = 0.008 R = –0.36, p = 0.008 R = –0.31, p = 0.036 –
Table 2 also shows significant correlations between normalized brain volume and clinical data and the volume and count of clustered lesions (CL-1, 1st Cluster; CL-2, 2nd cluster,
EDSS, Expanded Disability Status Scale). The bold values highlight the significant correlations.
FIGURE 4 | Clinical relevance of the lesion types. The subplots show the significant Spearman correlation plots (EDSS, Expanded Disability Status Scale; DD, disease
duration; Cl-2 count, lesion count in the Cluster #2; Cl-2 volume, lesion volume in the Cluster #2; TLV, total lesion volume; NBV, normalized brain volume).
by incorporating T1 relaxation times in the analysis (3). While
these studies only included SE images (personal communication),
the importance of intensity variation of T1 hypointense lesions
is clear. Along those lines, Adusumilli used a weighted lesion
burden in which intensity values closer to CSF contribute
most to the T1 hypointense lesion burden (15). Their measure
shows good correlation with clinical and cognitive functions of
the patients.
The importance of the intensity variation in the BHs is
also supported by the histopathological studies. The degree of
hypointensity correlated strongly with the axonal density in
the lesions but not with the degree of demyelination or the
number of reactive astrocytes (10). Fisher found that the contrast
ratio of the T1 and MTR images (lesion intensity compared to
the mean NAWM intensity) highly correlated with the axon
count (9). The contrast ratios (T1, MTR, and FLAIR) differed
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significantly between myelinated and demyelinated lesions, but
in the demyelinated lesions, the axon count correlated with the
T1 andMTR contrast ratio, but not with the FLAIR contrast ratio.
Importantly, chronic inactive lesions had the lowest contrast ratio
(darkest lesions) as compared to active and chronic active lesions.
The question arises: Why did Cluster 2, with the relatively
lighter lesions, show correlation with clinical measures, if the
most severe tissue destruction is at the darkest part of the
hypointense lesions? According to Fisher’s results, the most
hypointense part of the lesions are the inactive chronic lesions
(9). One might speculate that these lesions are the oldest; hence,
the most time was available for compensatory mechanisms and
neural plasticity.
Here we used an automatic clustering approach to
identify different types of lesions based on median intensity
values on commonly used sequences. There were already
studies to classify lesions, but some of those used images
not included in the standard clinical routine (e.g., DTI,
MTR, relaxometry) (30), or did not use a model-free
approach (31).
Our work is not without limitations. Acquiring SE and
FSPGR images with a set of different parameters would
strengthen our results. The different spatial resolution of the
two sequences might introduce a bias, but using these sequences
we were investigating a real-life problem. Investigating various
patient populations (RRMS and SPMS) and including patients
with contrast-enhancing active lesion could further elaborate
our findings.
CONCLUSION
Our results call attention to consider FSPGR and SE sequences
together when evaluating BHs. The clinical relevance of the
intensity variation of the hypointense lesion is critical. Further
studies are warranted to find a standardization approach and
cutoff values for the FSPGR images that could result in reducing
the number of measurements (e.g., skipping the SE sequence).
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